PET/CT helps predict mortality in metastatic breast cancer patients

09/14/2011 | (free registration)

Researchers at last week's American Society of Clinical Oncology Breast Cancer Symposium reported that in breast cancer patients with bone metastases, higher standardized uptake values on PET/CT scans could indicate greater risk of death. Prognostication for metastatic breast cancer has been difficult, but modern PET/CT may serve as a "complementary and clinically useful prognostic tool," said researcher Dr. Komal Jhaveri from the Memorial Sloan-Kettering Cancer Center in New York.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA
Assistant General Counsel, Regulatorya
Cardinal Health
Waukegan, IL
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA